Insulin glargine and lixisenatide and Minocycline mucous membrane powder
Determining the interaction of Insulin glargine and lixisenatide and Minocycline mucous membrane powder and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: minocycline topical
Brand name: Arestin
Synonyms: Minocycline (mucous membrane powder), Minocycline (Topical)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Minocycline Oral Suspension
- Insulin glargine and lixisenatide-Minocycline Subgingival
- Insulin glargine and lixisenatide-Minocycline Tablets
- Insulin glargine and lixisenatide-Minolira
- Insulin glargine and lixisenatide-Minox Topical
- Insulin glargine and lixisenatide-Minoxidil
- Minocycline mucous membrane powder-Insulin glargine and lixisenatide Subcutaneous
- Minocycline mucous membrane powder-Insulin glargine, recombinant Subcutaneous
- Minocycline mucous membrane powder-Insulin glulisine
- Minocycline mucous membrane powder-Insulin Glulisine (Cartridges and Pens)
- Minocycline mucous membrane powder-Insulin Glulisine (Vials)
- Minocycline mucous membrane powder-Insulin glulisine Subcutaneous